Ramathibodi Hospital, Mahidol University
Bangkok, 10400, Thailand
NCT Number: NCT04270331
The investigators proposed that pain, agitation, delirium and sleep deprivation protocol (PADS) will help improve the patients' outcomes (shortening ICU length of stay, improving ventilator free days, increasing delirium free days) in critically ill patients, a university hospital, Thailand.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Bangkok, 10400, Thailand
Pain is frequently reported in patients admitted to an ICU, with an incidence of up to 50% in medical patients during admission, and increasing up to 80% during standard care procedures. Agitation was also reported in 52% of the patients, typically within 4-9 days after admission. However, there were studies reporting inadequate pain, agitation and delirium assessment and management in real-world clinical practice. The clinical practice guideline for the management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU was recently published in 2018 and emphasized routinely monitoring pain, agitation and delirium during ICU admissions. Also, appropriate management of pain and agitation in critically ill patients resulted in reduction in ICU length of stay, hospital length of stay, delirium and mortality. Therefore, structural pain, agitation/sedation, delirium assessment and treatment in the ICUs, Thailand might be necessary.
Since pain, agitation/sedation and delirium protocol has not yet been initiated in ICUs, Thailand, this study is designed as a before-after study in order to assess outcomes by comparing between before and after protocol initiation. The objectives of the study were to document the impact of pain, agitation/sedation, delirium protocol on clinical outcomes of ICU patients admitted to ICUs at Ramathibodi Hospital, a university hospital, Thailand
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Assessment and management per PADS protocol
Time frame: During ICU stay or death or a maximum of 28 days
Days alive and not stay in ICU
Time frame: During ICU stay or death or a maximum of 28 days
Day alive and free of mechanical ventilator
Time frame: During ICU stay or death or a maximum of 28 days
Day alive and free of delirium
Time frame: During ICU stay or death or a maximum of 28 days
Times per patient-days of evaluations during ICU stay
Time frame: During ICU stay or death or a maximum of 28 days
Times per patient-days of in-target pain, agitation/sedation, delirium during ICU stay
Time frame: During ICU stay or death or a maximum of 28 days
Times per patient-days of PADS protocol use by healthcare providers during ICU stay
Time frame: During hospital stay or death or a maximum of 90 days
Rates of all-cause mortality during hospital stay
Time frame: During ICU stay or death or a maximum of 28 days
Type and dose of antipsychotics during ICU stay
Time frame: During ICU stay or death or a maximum of 28 days
Type and dose of non-benzodiazepines during ICU stay
Time frame: During ICU stay or death or a maximum of 28 days
Type and dose of non-benzodiazepines during ICU stay
Mahidol University
Other
Pain, Agitation, Delirium and Sleep Deprivation Assessment and Management in Intensive Care Units, Thailand: a Before-after Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03773874
Aberrant Motor Behavior in Dementia, Agitation
Getafe, Madrid, Spain
View Trial DetailsNCT02863081
Aberrant Motor Behavior in Dementia, Agitation
Columbus, Ohio, United States
View Trial DetailsNCT05384613
Confusion, Delirium
Berlin, Germany
View Trial DetailsNCT06339385
Agitation, Emergence, Confusion
Beijing, Beijing Municipality, China
View Trial Details